Stellar Biotechnologies Acquires Exclusive, Worldwide License to University of Guelph Clostridium Difficile Immunotherapy Technology
Stellar Biotechnologies Acquires Exclusive, Worldwide License to University of Guelph Clostridium Difficile Immunotherapy Technology
News Release: